In-Vitro Testing New Psychoactive Substances (IVT NPS)

Tender description

There is a requirement to continue procuring a service for in-vitro testing of potentially psychoactive substances to support the implementation of the Psychoactive Substances Act (2016). The testing involves pharmacological testing on immobilised cloned human cells against suspected psychoactive substances. Dstl are seeking to establish a 5 Year call off arrangement, with the option for a 1 Year contract extension which falls below DSPCR thresholds. The decision to proceed with a non-competitive procurement, with Eurofins Cerep SA, has been approved on the basis of Technical grounds under Regulation 16(1)(a)(ii).